More than a decade ago, the American Society of Clinical Oncology (ASCO) initiated CancerLinQ, a pioneering platform designed with the…
Read More
How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform
Over a decade ago, the American Society of Clinical Oncology (ASCO) initiated a groundbreaking endeavor with the launch of CancerLinQ,…
Read More
Pens to Pills: The Transformative Era of Oral GLP-1 Receptor Agonists in Drug Discovery and Patient Care
The pharmaceutical landscape for metabolic diseases has reached a pivotal inflection point, marked by the recent approval of the first…
Read More
How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform
In a significant advancement for precision oncology, ConcertAI, a leading AI and real-world data company focused on cancer care, has…
Read More
Eli Lilly and Oura Health Forge Strategic Alliance to Pioneer Integrated Obesity Care
The landscape of obesity treatment is undergoing a profound transformation, moving beyond purely pharmaceutical interventions to embrace a holistic ecosystem…
Read More
FDA Approves a Wave of Oncology Innovations: New Therapies, Diagnostics, and Imaging Agents Usher in a New Era of Cancer Care
The US Food and Drug Administration (FDA) has recently authorized a series of significant advancements in oncology, encompassing novel therapeutic…
Read More
NYU Langone Health Leaders Unveil Visionary Strides in Digital Pathology, Revolutionizing Diagnostic Services and Patient Care
In a landmark presentation that underscored the transformative potential of advanced medical technology, Christina Baranetsky, Senior Administrative Director of Pathology…
Read More
Advanced Blood Analysis of Immune Cell Aging Offers New Pathway for Objective Depression Diagnosis and Precision Mental Health Care
The landscape of psychiatric medicine is undergoing a significant shift as researchers move closer to replacing subjective symptom reporting with…
Read More
Darzalex Secures Landmark European Approval for Self-Administration in Multiple Myeloma, Ushering in a New Era of Home-Based Cancer Care
Johnson & Johnson’s (J&J) groundbreaking cancer immunotherapy, Darzalex (daratumumab), has achieved a pivotal milestone in its European market penetration with…
Read More
Viz.ai and Alnylam Forge Strategic Alliance to Revolutionize Cardiac Amyloidosis Diagnosis and Care
In a significant development poised to reshape the landscape of cardiovascular medicine, Viz.ai has announced a groundbreaking collaboration with Alnylam…
Read MoreYOU MAY HAVE MISSED
